Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma

By sjmartinez • March 14, 2023

Corren J, Wechsler ME, Chupp G, Roseti SL, Hellqvist Å, Martin N, Llanos JP, Ambrose CS, Colice G. Efficacy and safety of tezepelumab in patients with uncontrolled disease while receiving maintenance therapy for moderate or severe asthma. J Allergy Clin Immunol Pract. 2023 Mar;11(3):943-945.e2. doi: 10.1016/j.jaip.2022.10.042. Epub 2022 Nov 11. PMID: 36375743.

Tags: Allergy & Immunology, Publications

Leveraging Learning Systems to Improve Quality and Patient Safety in Allergen Immunotherapy

Conway AE, Rupprecht C, Bansal P, Yuan I, Wang Z, Shaker MS, Verdi M, Bradley J. Leveraging Learning Systems to Improve Quality and Patient Safety[...]

APDS patients with immune-complex vasculitis and resolution with leniolisib

Dorodouchi MA, Stephens AV, Wang Z, Dhami J, Butte MJ. APDS patients with immune-complex vasculitis and resolution with leniolisib. Clin Immunol. 2024 Mar 8:110176. doi:[...]

Year 2. October 9. Celebrating Our Commitment to Health Equity.

Throughout Southern California, department of medicine (DoM) faculty are providing essential medical care to communities in high need. You may find faculty at community hospital[...]